Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking

被引:0
作者
Xia Lu
Lingzhou Zhao
Tian Xue
Huabei Zhang
机构
[1] Beijing Normal University,Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry
[2] Beijing Aerospace Hospital,Medical Image Center
来源
Medicinal Chemistry Research | 2014年 / 23卷
关键词
Focal adhesion kinase; Inhibitors; Docking; 3D-QSAR; CoMFA; CoMSIA;
D O I
暂无
中图分类号
学科分类号
摘要
Focal adhesion kinase (FAK) plays a primary role in regulating the activity of many signaling molecules. Increased FAK expression has been implicated in a series of cellular processes, including cell migration and survival. Inhibiting the activity of FAK for cancer therapy is currently under investigation. Hence, FAK and its inhibitors have been the subject of intensive research. To understand the structural factors affecting inhibitory potency, molecular docking and 3D-QSAR modeling were studied in this project. CoMFA and CoMSIA methods were used for deriving 3D-QSAR models, which were trained with 78 compounds and then were evaluated for predictive ability with additional 19 compounds. Two substructure-based 3D-QSAR models, including CoMFA model (r2 = 0.930; q2 = 0.629) and CoMSIA model (r2 = 0.952; q2 = 0.586), had a good quality to predict the biological activities of new compounds. Meanwhile, using the flexible docking strategy, two docking-based 3D-QSAR models (CoMFA with r2 = 0.914; q2 = 0.594; CoMSIA with r2 = 0.914; q2 = 0.524) were also constructed. The structure–activity relationship has been illustrated clearly by the contour maps gained from the 3D-QSAR models in combination with the docked binding structures. All the results indicated that it might be useful in the rational design of novel FAK inhibitors.
引用
收藏
页码:1976 / 1997
页数:21
相关论文
共 390 条
  • [1] Bagi CM(2008)Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases Cancer 112 2313-2321
  • [2] Roberts GW(2009)Sunitinib and PF-562,271(FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model Cancer Biol Ther 8 856-865
  • [3] Andresen CJ(2008)TAE226 inhibits human neuroblastoma cell survival Cancer Invest 26 145-151
  • [4] Bagi CM(2010)Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma Cell Cycle 9 1005-1015
  • [5] Christensen J(1993)Sample-distance partial least squares: PLS optimized variables, with the application to CoMFA J Comput Aided Mol Des 7 587-619
  • [6] Cohen DP(2006)Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 2 Bioorg Med Chem Lett 16 2689-2692
  • [7] Roberts WG(2006)Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors. Part 1 Bioorg Med Chem Lett 16 2173-2176
  • [8] Wilkie D(1989)Validation of the general purpose tripos 5.2 force field J Comput Chem 10 982-1012
  • [9] Swanson T(1994)Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK Mol Cell Biol 14 147-155
  • [10] Tuthill T(2009)FXR promotes endothelial cell motility through coordinated regulation of FAK and MMP-9 Arterioscler Thromb Vasc Biol 29 562-570